Mirum Pharmaceuticals (MIRM) revenue

Revenue · fiscal 2025
$521.31M

Mirum Pharmaceuticals (MIRM) reported revenue of $521.31M in fiscal 2025 (the year ended December 31, 2025). That is 54.7% higher than the $336.89M of fiscal 2024. Figures as of 18 Nov 2026, 09:54 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$521.31M
Change on fiscal 2024
+54.7%
Highest on record
$521.31Mfiscal 2025
Lowest on record
$19.14Mfiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Mirum Pharmaceuticals revenue, in more detail

Across the 5 fiscal years on record (2021–2025), the highest was $521.31M in fiscal 2025 and the lowest $19.14M in fiscal 2021.

History · 5 fiscal years

Revenue by fiscal year

Mirum Pharmaceuticals revenue, year by year

Mirum Pharmaceuticals (MIRM) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$521.31M 54.7% up
2024$336.89M 80.8% up
2023$186.37M 141.8% up
2022$77.06M 302.7% up
2021$19.14M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Mirum Pharmaceuticals and comparable companies
CompanyRevenueFiscal year
Scholar Rock Holding SRRK$33.19M2022
Teleflex TFX$1.99B2025
Mirum Pharmaceuticals MIRM$521.31M2025
Grifols GRFS€7.52B2025
Cogent Biosciences COGT$7.87M2020

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MIRM

Mirum Pharmaceuticals, figure by figure

Mirum Pharmaceuticals (MIRM) overview: price, valuation and scorecardAll health care companies by market value

Mirum Pharmaceuticals revenue: questions and answers

What is Mirum Pharmaceuticals's revenue?

Mirum Pharmaceuticals (MIRM) reported revenue of $521.31M in fiscal 2025 (the year ended December 31, 2025). That is 54.7% higher than the $336.89M of fiscal 2024.

What are the highest and lowest revenue figures on record for Mirum Pharmaceuticals?

Across the 5 fiscal years on record (2021–2025), the highest was $521.31M in fiscal 2025 and the lowest $19.14M in fiscal 2021.

How is Mirum Pharmaceuticals's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Mirum Pharmaceuticals it is on record here for 5 fiscal years, 2021 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Mirum Pharmaceuticals (MIRM) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/MIRM/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.